We are live on ! Find out more
BAMS

Bellevue Asset Management (Switzerland) Portfolio holdings

AUM $656M
1-Year Est. Return 11.45%
This Fund
S&P 500
This Quarter Est. Return
-14.54%
1 Year Est. Return
+11.45%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$613M
AUM Growth
-$108M
Cap. Flow
+$11.4M
Cap. Flow %
1.86%
Top 10 Hldgs %
30.19%
Holding
150
New
11
Increased
47
Reduced
31
Closed
17

Top Buys

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$5.95M
2
LRMR icon
Larimar Therapeutics
LRMR
+$3.76M
3
AMGN icon
Amgen
AMGN
+$3.65M
4
INSY
Insys Therapeutics, Inc.
INSY
+$3.31M
5
HALO icon
Halozyme
HALO
+$3.1M

Top Sells

Rank Stock Value
1
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$6.46M
2
CAH icon
Cardinal Health
CAH
+$3.59M
3
KITE
Kite Pharma, Inc.
KITE
+$3.49M
4
MDVN
MEDIVATION, INC.
MDVN
+$3.47M
5
ALKS icon
Alkermes
ALKS
+$3.33M

Sector Composition

Rank Sector Weight
1 Healthcare 91.86%
2 Financials 0.95%
3 Industrials 0.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCK icon
26
McKesson
MCK
$103B
$7.59M 1.24%
41,000
– –
JAZZ icon
27
Jazz Pharmaceuticals
JAZZ
$16.7B
$7.44M 1.21%
56,000
– –
CYH icon
28
Community Health Systems
CYH
$415M
$6.94M 1.13%
196,431
+17,048
+10% +$782K
BMRN icon
29
BioMarin Pharmaceuticals
BMRN
$13.3B
$6.85M 1.12%
65,000
– –
KITE
30
DELISTED
Kite Pharma, Inc.
KITE
$6.65M 1.09%
119,500
-55,500
-32% -$3.49M
BSX icon
31
Boston Scientific
BSX
$73.1B
$6.56M 1.07%
400,000
– –
SHPG
32
DELISTED
Shire pic
SHPG
$6.34M 1.03%
30,890
+3,090
+11% +$735K
EW icon
33
Edwards Lifesciences
EW
$53B
$6.33M 1.03%
267,000
+62,400
+30% +$1.51M
PRGO icon
34
Perrigo
PRGO
$1.75B
$6.29M 1.03%
40,000
– –
ISRG icon
35
Intuitive Surgical
ISRG
$139B
$6.23M 1.02%
121,950
– –
CAH icon
36
Cardinal Health
CAH
$55.5B
$6.15M 1%
80,000
-43,000
-35% -$3.59M
INSY
37
DELISTED
Insys Therapeutics, Inc.
INSY
$5.98M 0.97%
210,000
+90,000
+75% +$3.31M
AET
38
DELISTED
Aetna Inc
AET
$5.8M 0.95%
53,000
+8,000
+18% +$924K
COR icon
39
Cencora
COR
$62B
$5.7M 0.93%
60,000
– –
HUM icon
40
Humana
HUM
$46.3B
$5.37M 0.88%
30,000
+6,500
+28% +$1.2M
IONS icon
41
Ionis Pharmaceuticals
IONS
$9.46B
$5.33M 0.87%
132,000
+10,000
+8% +$518K
CVS icon
42
CVS Health
CVS
$122B
$5.31M 0.87%
55,000
+5,000
+10% +$526K
MNK
43
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$5.12M 0.83%
80,000
+30,000
+60% +$2.97M
CLVS
44
DELISTED
Clovis Oncology, Inc.
CLVS
$5.06M 0.83%
55,000
-100
-0.2% -$8.65K
XENT
45
DELISTED
Intersect ENT, Inc
XENT
$4.67M 0.76%
199,777
+69,777
+54% +$1.93M
THC icon
46
Tenet Healthcare
THC
$20.9B
$4.67M 0.76%
126,510
+4,560
+4% +$236K
JNJ icon
47
Johnson & Johnson
JNJ
$631B
$4.67M 0.76%
50,000
– –
CHRS icon
48
Coherus Oncology
CHRS
$192M
$4.61M 0.75%
230,000
-20,000
-8% -$609K
BCR
49
DELISTED
CR Bard Inc.
BCR
$4.57M 0.74%
24,500
-5,500
-18% -$1.04M
SUPN icon
50
Supernus Pharmaceuticals
SUPN
$2.74B
$4.49M 0.73%
+320,000
New +$5.95M
1
2
3 4 5

Similar funds

VFAM
Valley Forge Asset Management King Of Prussia, Pennsylvania $645M AUM 5.8% 1-Year Est. Return
MSU
Maple Securities USA Jersey City, New Jersey $672M AUM 1.03% 1-Year Est. Return
PSI
Pinnacle Summer Investments Fairfax, Virginia $678M AUM 9.5% 1-Year Est. Return
SFP
Santa Fe Partners Santa Fe, New Mexico $608M AUM 8.76% 1-Year Est. Return
MCM
Mazama Capital Management Portland, Oregon $544M AUM 9.52% 1-Year Est. Return
NMIS
Northwestern Mutual Investment Services Milwaukee, Wisconsin $525M AUM 2.45% 1-Year Est. Return
SM
Stratton Management King Of Prussia, Pennsylvania $824M AUM 1.57% 1-Year Est. Return
ZAM
Zenit Asset Management Stockholm, Sweden $450M AUM 8.32% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s Q3 2015 Portfolio in Review

As of Q3 2015, Bellevue Asset Management (Switzerland) held 150 positions worth $613M, down 15% from $721M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bellevue Asset Management (Switzerland)'s Q3 2015 filing shows 11 new, 47 increased, 31 reduced and 17 closed positions. Its largest new stake was Supernus Pharmaceuticals: 320,000 shares worth $4.49M. The largest sale was RECEPTOS INC COM STK (DE), an estimated $6.46M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 90% a quarter earlier, followed by Financials and Industrials.

  • Bellevue Asset Management (Switzerland)'s largest Q3 2015 buy was Supernus Pharmaceuticals: 320,000 shares worth $4.49M.
  • Bellevue Asset Management (Switzerland) added most to Amgen in Q3 2015, an estimated $3.65M increase.
  • Bellevue Asset Management (Switzerland)'s biggest Q3 2015 reduction was Cardinal Health, cutting an estimated $3.59M.
  • Bellevue Asset Management (Switzerland) fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $6.46M.
  • Bellevue Asset Management (Switzerland)'s ten largest holdings make up 30% of its $613M portfolio in Q3 2015.
  • Bellevue Asset Management (Switzerland) opened 11 new positions and closed 17 in Q3 2015.
  • Bellevue Asset Management (Switzerland)'s portfolio value fell 15% quarter-over-quarter to $613M.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q3 2015, filed 12 Nov 2015.